Literature DB >> 32580712

Ancestry effects on type 2 diabetes genetic risk inference in Hispanic/Latino populations.

Aroon T Chande1,2,3, Lavanya Rishishwar2,3, Andrew B Conley2,3, Augusto Valderrama-Aguirre1,3,4,5, Miguel A Medina-Rivas3,6, I King Jordan7,8,9.   

Abstract

BACKGROUND: Hispanic/Latino (HL) populations bear a disproportionately high burden of type 2 diabetes (T2D). The ability to predict T2D genetic risk using polygenic risk scores (PRS) offers great promise for improved screening and prevention. However, there are a number of complications related to the accurate inference of genetic risk across HL populations with distinct ancestry profiles. We investigated how ancestry affects the inference of T2D genetic risk using PRS in diverse HL populations from Colombia and the United States (US). In Colombia, we compared T2D genetic risk for the Mestizo population of Antioquia to the Afro-Colombian population of Chocó, and in the US, we compared European-American versus Mexican-American populations.
METHODS: Whole genome sequences and genotypes from the 1000 Genomes Project and the ChocoGen Research Project were used for genetic ancestry inference and for T2D polygenic risk score (PRS) calculation. Continental ancestry fractions for HL genomes were inferred via comparison with African, European, and Native American reference genomes, and PRS were calculated using T2D risk variants taken from multiple genome-wide association studies (GWAS) conducted on cohorts with diverse ancestries. A correction for ancestry bias in T2D risk inference based on the frequencies of ancestral versus derived alleles was developed and applied to PRS calculations in the HL populations studied here.
RESULTS: T2D genetic risk in Colombian and US HL populations is positively correlated with African and Native American ancestry and negatively correlated with European ancestry. The Afro-Colombian population of Chocó has higher predicted T2D risk than Antioquia, and the Mexican-American population has higher predicted risk than the European-American population. The inferred relative risk of T2D is robust to differences in the ancestry of the GWAS cohorts used for variant discovery. For trans-ethnic GWAS, population-specific variants and variants with same direction effects across populations yield consistent results. Nevertheless, the control for bias in T2D risk prediction confirms that explicit consideration of genetic ancestry can yield more reliable cross-population genetic risk inferences.
CONCLUSIONS: T2D associations that replicate across populations provide for more reliable risk inference, and modeling population-specific frequencies of ancestral and derived risk alleles can help control for biases in PRS estimation.

Entities:  

Keywords:  Antioquia; Chocó; Colombia; Genetic ancestry; Genetic risk; Hispanic/Latino (HL); Polygenic risk score (PRS); Population genetics; Type 2 diabetes (T2D)

Year:  2020        PMID: 32580712     DOI: 10.1186/s12881-020-01068-0

Source DB:  PubMed          Journal:  BMC Med Genet        ISSN: 1471-2350            Impact factor:   2.103


  8 in total

1.  Genetic European Ancestry and Incident Diabetes in Black Individuals: Insights From the SPRINT Trial.

Authors:  Vibhu Parcha; Brittain Heindl; Rajat Kalra; Adam Bress; Shreya Rao; Ambarish Pandey; Barbara Gower; Marguerite R Irvin; Merry-Lynn N McDonald; Peng Li; Garima Arora; Pankaj Arora
Journal:  Circ Genom Precis Med       Date:  2022-01-28

2.  Genome-wide risk prediction of common diseases across ancestries in one million people.

Authors:  Nina Mars; Sini Kerminen; Yen-Chen A Feng; Masahiro Kanai; Kristi Läll; Laurent F Thomas; Anne Heidi Skogholt; Pietro Della Briotta Parolo; Benjamin M Neale; Jordan W Smoller; Maiken E Gabrielsen; Kristian Hveem; Reedik Mägi; Koichi Matsuda; Yukinori Okada; Matti Pirinen; Aarno Palotie; Andrea Ganna; Alicia R Martin; Samuli Ripatti
Journal:  Cell Genom       Date:  2022-04-13

3.  Common BMI and diabetes-related genetic variants: A pilot study among indigenous people in the Brazilian Amazon.

Authors:  Isabela Guerreiro Diniz; Rosilene Reis Della Noce; Ana Paula Pereira; Aylla Núbia Lima Martins da Silva; Eliene Rodrigues Putira Sacuena; Renan Barbosa Lemes; Greice de Lemos Cardoso-Costa; Gilderlânio Santana Araújo; Jéssica Lígia Picanço Machado; Fernanda Andreza de Pinho Lott Figueiredo; Tábita Hümemeier; João Farias Guerreiro
Journal:  Genet Mol Biol       Date:  2022-05-11       Impact factor: 2.087

4.  Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes.

Authors:  William S Gange; Jennifer Lopez; Benjamin Y Xu; Khristina Lung; Seth A Seabury; Brian C Toy
Journal:  Diabetes Care       Date:  2021-09-02       Impact factor: 19.112

Review 5.  Type 2 Diabetes Mellitus in Latinx Populations in the United States: A Culturally Relevant Literature Review.

Authors:  Therese M Vidal; Caitlin A Williams; Uma D Ramoutar; Farzanna Haffizulla
Journal:  Cureus       Date:  2022-03-15

6.  The Phenotypic Consequences of Genetic Divergence between Admixed Latin American Populations: Antioquia and Chocó, Colombia.

Authors:  Aroon T Chande; Lavanya Rishishwar; Dongjo Ban; Shashwat D Nagar; Andrew B Conley; Jessica Rowell; Augusto E Valderrama-Aguirre; Miguel A Medina-Rivas; I King Jordan
Journal:  Genome Biol Evol       Date:  2020-09-01       Impact factor: 3.416

7.  Socioeconomic deprivation and genetic ancestry interact to modify type 2 diabetes ethnic disparities in the United Kingdom.

Authors:  Shashwat Deepali Nagar; Anna María Nápoles; I King Jordan; Leonardo Mariño-Ramírez
Journal:  EClinicalMedicine       Date:  2021-06-14

8.  Generalizability of Polygenic Risk Scores for Breast Cancer Among Women With European, African, and Latinx Ancestry.

Authors:  Cong Liu; Nur Zeinomar; Wendy K Chung; Krzysztof Kiryluk; Ali G Gharavi; George Hripcsak; Katherine D Crew; Ning Shang; Atlas Khan; David Fasel; Teri A Manolio; Gail P Jarvik; Robb Rowley; Ann E Justice; Alanna K Rahm; Stephanie M Fullerton; Jordan W Smoller; Eric B Larson; Paul K Crane; Ozan Dikilitas; Georgia L Wiesner; Alexander G Bick; Mary Beth Terry; Chunhua Weng
Journal:  JAMA Netw Open       Date:  2021-08-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.